Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Gefjon Pharma ApS
APS
Active
Advertising protection
CVR 44512971
Ole Maaløes Vej 3, 2200
København N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2023 · 2 years old
7 employees
www.gefjonpharma.com
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Gefjon Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
FA
Fabio Antenucci
Management
Management
2025
TH
Torben Hald
Chief Executive Officer
Chief Executive Officer
2024
TF
Thomas Frees Buthler
Management
Management
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
AM
Anders Miki Bojesen
Chairman
Chairman
2026
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
TBU Holding 2023 ApS
Company
25–33.32%
25–33.32%
2023
HAVITO AS
Individual
25–33.32%
25–33.32%
2023
Copenhagen Equity ApS
Company
25–33.32%
25–33.32%
2023
North2k ApS
Company
25–33.32%
25–33.32%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Gefjon Pharma ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network